JCI - Comments

Submit a comment

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

Callum Beach, … , Amato J. Giaccia, Monica M. Olcina

Published August 15, 2024
Citation Information: J Clin Invest. 2024;134(16):e185067. https://doi.org/10.1172/JCI185067.

View: Text | PDF | Amended Article

Corrigendum

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

Comments appear on the Journal’s website and are linked from the original article’s web page.
Authors are notified by email if their comments are posted.
The Journal reserves the right to edit comments for length and clarity.
No appeals will be considered.
Comments are not indexed in PubMed.

Specific requirements

Maximum length, 400 words
Entered as plain text or HTML
Author’s name and email address, to be posted with the comment
Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
Comments may not include figures

First name This field is required

Last name This field is required

Position This field is required

Institution This field is required

Email address This field is required

Other authors (Enter the list of colleagues in the following form: Stephanie Fulton, Thomas L. Wilding, and Frances Groen.)

Title This field is required

Comment (maximum 400 words) and conflict-of-interest statement

Rich Text Editor, eletter_body

Editor toolbars

Press ALT 0 for help

◢Elements path

Submit a comment

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

Abstract

Authors

Guidelines

Specific requirements

Sign up for email alerts